Search for: "TEVA PHARMACEUTICALS v. ELI LILLY AND COMPANY " Results 1 - 20 of 84
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Sep 2015, 9:59 pm by Patent Docs
District Court Finds Lilly Patent Infringed Based on Inducement of Infringement by Single Actor By Donald Zuhn -- Last week, in Eli Lilly and Company v. [read post]
24 Feb 2009, 9:43 pm
Seeking approval to manufacture and market a generic version of Plaintiff-Appellee Eli Lilly and Company's raloxifene hydrochloride formulation, which Lilly markets as Evista ® for the treatment and prevention of postmenopausal osteoporosis, Teva filed an ANDA with the FDA in 2006. [read post]
1 Aug 2011, 8:19 am
. - Indianapolis-based Eli Lilly & Co. won a lawsuit against seven other pharmaceutical companies that sought FDA approval to sell competing drugs that would have utilized Lilly's patented drug formula. [read post]
11 Jan 2013, 4:00 am by Paula Bremner
Eli Lilly and Company Limited, [2009] EWCA Civ 1362) It was clear this was coming The Supreme Court of Canada (“SCC”) recently invalidated Pfizer’s Viagra patent based on insufficiency (Teva v. [read post]
27 Dec 2006, 4:14 pm
Here is a link to the United States Court of Appeals for the Federal Circuit 23-page opinion in the case of Eli Lilly v. [read post]
17 Mar 2014, 11:03 am
Reddy's Laboratories, Inc.; Glenmark Generics Inc., USA; Glenmark Generics Ltd.; Glenmark Pharmaceuticals Ltd.; Hetero USA Inc.; Hetero Labs Limited; Hetero Labs Limited Unit V; Hetero Drugs Ltd.; Mylan Pharmaceuticals Inc.; Mylan Inc.; Mylan Laboratories Limited (these three companies are, collectively, "Mylan"); Par Pharmaceutical Companies, Inc.; Par Pharmaceutical, Inc.; Sun Pharma Global FZE; Caraco Pharmaceutical… [read post]
Joining the majority of European courts, the Paris Court of Justice ruled that Eli Lilly’s patent, which relates to the combined administration of pemetrexed disodium and vitamin B12, was infringed by the marketing of Fresenius’ pemetrexed diacid. [read post]
17 Jul 2014, 10:58 am
Reddy's Laboratories, Inc.; Glenmark Generics Inc., USA; Glenmark Generics Ltd.; Glenmark Pharmaceuticals Ltd.; Hetero USA Inc.; Hetero Labs Limited; Hetero Labs Limited Unit V; Hetero Drugs Ltd.; Mylan Pharmaceuticals Inc.; Mylan Inc.; Mylan Laboratories Limited; Par Pharmaceutical Companies, Inc.; Par Pharmaceutical, Inc.; Sun Pharma Global FZE; Caraco Pharmaceutical Laboratories, Ltd.; Sun Pharma Global Inc.; Sun… [read post]
30 Jun 2014, 10:28 am
Reddy's Laboratories, Inc.; Glenmark Generics Inc., USA; Glenmark Generics Ltd.; Glenmark Pharmaceuticals Ltd.; Hetero USA Inc.; Hetero Labs Limited; Hetero Labs Limited Unit V; Hetero Drugs Ltd.; Mylan Pharmaceuticals Inc.; Mylan Inc.; Mylan Laboratories Limited; Par Pharmaceutical Companies, Inc.; Par Pharmaceutical, Inc.; Sun Pharma Global FZE; Caraco Pharmaceutical Laboratories, Ltd.; Sun Pharma Global Inc.; Sun… [read post]
23 Dec 2009, 12:40 am
Sandoz Limited (EPLAW) Fuzeon (Enfuvirtide) - US: If there are no sources of proof in the E D of Texas, expect to transferred: In re Hoffman-La Roche Inc (Filewrapper) Gemzar (Gemcitabine) – US: Eli Lilly appeals from grant of partial summary judgment finding certain claims invalid for double patenting: Sun Pharma v Eli Lilly (PATracer) Gemzar (Gemcitabine) – US: Eli Lilly files patent infringement complaint against APP… [read post]
31 Aug 2010, 10:01 pm by Kelly
– state of research and development of new drugs in Indian pharma industry (Spicy IP) US: The Financial Times’ take on gene patenting (Patent Docs) US: Seattle Biotech companies fight over allegedly similar names: Mirina Corp. v. [read post]